https://www.marketscreener.com/quote/stock/ESSA-PHARMA-INC-44458541/news/ESSA-Pharma-Inc-Announces-Initiation-of-Phase-2-Study-Evaluating-Masofaniten-EPI-7386-in-Combinat-44867466/?utm_source=telegram&utm_medium=social&utm_campaign=share